Dr. Rimner is a radiation oncologist and Scientific Director at the Comprehensive Cancer Center of Freiberg in Baden-Württemberg, Germany. He previously worked with a multidisciplinary team at Memorial Sloan Kettering Cancer Center to identify the best treatment options for patients diagnosed with thoracic cancers, like mesothelioma. Education and Career Dr. Rimner graduated from the Eberhard-Karls-Universität
Dr. Pennell is a board-certified medical oncologist who has spent more than two decades in clinical practice, specializing in the treatment of thoracic malignancies, including pleural mesothelioma and lung cancer. He is now a Senior Vice President and head of Global Medical Oncology for Bristol Myers Squibb. Education and Career After graduating from the University
Dr. Zauderer is a leading medical oncologist and researcher specializing in caring for people with thoracic cancers, including pleural mesothelioma. As Professor of Medicine of Westchester Medical Center’s Division of Hematology and Neoplastic Diseases and Medicine in the Division of Oncology, she works with a multidisciplinary team of thoracic surgeons, radiation oncologists, pulmonologists, pathologists, radiologists,
Dr. Prasad S. Adusumilli is a thoracic surgeon and cellular therapist at the renowned Memorial Sloan Kettering Cancer Center. He specializes in treating patients with lung cancer, pleural mesothelioma, and metastatic cancers to the lung and is skilled in early diagnosis and accurate staging. Dr. Adusumilli also heads a cellular research laboratory focused on developing
Dr. Richard James Battafarano is a thoracic surgeon in the Johns Hopkins Department of Surgery. He is both the Director of the Division of General Thoracic Surgery and Johns Hopkins’ first regional director of general thoracic surgery. He specializes in minimally invasive surgeries and video-assisted thoracoscopic surgery for the treatment of chest diseases like pleural
Dr. Forde is a medical oncologist and researcher specializing in thoracic cancers like mesothelioma, and researching the impact of immunotherapy in the treatment of lung cancer and mesothelioma. He currently divides his time between Johns Hopkins University and Trinity College Dublin. Education and Career Dr. Forde’s medical education began in Ireland, where he earned his
Dr. Albelda is a pulmonologist, researcher, and leading expert in the field of thoracic oncology and pleural mesothelioma. He is a member of the Penn Abramson Cancer Center and holds leadership roles there and at the University of Pennsylvania. His research focuses on developing novel approaches to the treatment of mesothelioma, lung cancers, and other thoracic
Dr. Keith Cengel is a board-certified radiation oncologist practicing in Philadelphia, Pennsylvania. He is the Executive Director of Penn Mesothelioma and the Pleural Diseases Program. As Director of the Photodynamic Therapy Program, he has special expertise in the use of advanced radiation therapy protocols to treat pleural mesothelioma. Education and Career Dr. Cengel attended the
Dr. Lambright is a general thoracic surgeon with special interests in pulmonary malignancies, including mesothelioma. He has conducted extensive research in novel therapies for chest malignancies, including cancer gene therapies. In addition to his work at Vanderbilt, he is Chief of Thoracic Surgery at Nashville Veterans’ Affairs Hospital. Education and Career Born in Adidome, Ghana, Africa,
Unlike the United States, many countries in Europe and across the world have banned the use of asbestos in order to lower the risk of malignant mesothelioma and other asbestos-related diseases. But the continued presence of asbestos in already-built structures continues to pose a threat, and together with the European Parliament, the Council of the